Examination of interaction between regulatory domain of
tyrosine hydroxylase and 14-3-3 protein
A. Brzóstowicz1,2, M. Makovická1,2
1. CEITEC-MU, Kamenice 5, 625 00, Brno, Czech Republic,
jozef.hritz@gmail.com
2. National Centre for Biomolecular Research, Faculty of
Science, Masaryk University, Kamenice 5, 625 00 Brno, Czech Republic
al.brzostowicz@gmail.com
Tyrosine hydroxylase (TH) is the rate-limiting
enzyme in catecholamine biosynthesis belonging to aromatic amino acid
hydroxylases (AAAHs) family [1]. Enzymatic reaction results in hydroxylation of
L-tyrosine into L-DOPA, a precursor of crucial neurotransmitters in human body:
dopamine, norepinephrine and epinephrine which deficiencies lead to
neurological disorders like Alzheimer disease, dystonia and Segawa syndrome [2].
TH has a multi-domain structure with
unstructured amino-terminal regulatory domain (RD) followed by catalytic domain
and coiled-coil domain responsible for oligomerization at the carboxyl
terminus. Enzyme activation is mostly held by phosphorylation of both Ser-19
and Ser-40 residues [3]. These two modifications enable to form a complex with
14-3-3 protein with high affinity and provides TH stabilization and proteolytic
protection of the regulatory domain N-terminus [3]. Although TH was first
reported enzyme interacting with 14-3-3 protein, the exact mode of its
regulation still needs further investigation to provide the molecular targets
in drug development [4].
[1] Kaufman, S. (1985). Regulatory properties of
phenylalanine, tyrosine and tryptophan hydroxylases. Biochemical
Society Transactions, 13(2), 433–436.
[2] Willemsen, M. A., Verbeek, M. M., Kamsteeg, E.-J.,
de Rijk-van Andel, J. F., Aeby, A., Blau, N., Wevers,
R. A. (2010). Tyrosine hydroxylase deficiency: a treatable disorder of brain
catecholamine biosynthesis. Brain, 133(6), 1810–1822.
[3] Daubner, S. C., Le, T., & Wang, S. (2011). Tyrosine hydroxylase and regulation of dopamine synthesis. Archives
of Biochemistry and Biophysics, 508(1), 1–12.
[4] Ichimura, T., Isobe, T., Okuyama, T., Yamauchi,
T., & Fujisawa, H. (1987). Brain 14-3-3 protein is an activator protein that
activates tryptophan 5-monooxygenase and tyrosine 3-monooxygenase in the
presence of Ca2+,calmodulin-dependent protein kinase II. FEBS
Letters, 219(1), 79–82.